The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.14), $0.06 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.27 million versus the consensus estimate of $109.15 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.